Tissue Regenix Group Plc (TRX) — Capital Reinvestment Ratio
Tissue Regenix Group Plc (TRX) has a Capital Reinvestment Ratio of 0.11x as of December 2023, meaning it reinvests 0% of its operating cash flow (GBX1.36 Million) in capital expenditures (GBX153.75K). Check Tissue Regenix Group Plc (TRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tissue Regenix Group Plc Capital Reinvestment Ratio (2023–2023)
This chart tracks Tissue Regenix Group Plc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see TRX cash flow conversion.
Annual Capital Reinvestment Ratio for Tissue Regenix Group Plc (2023–2023)
Year-by-year Capital Reinvestment Ratio for Tissue Regenix Group Plc from 2023 to 2023. See Tissue Regenix Group Plc (TRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.83x | GBX1.04 Million | GBX863.00K | — |